Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer

• Main Authors: Chitapanarux I., Tharavichitkul E., Lorvidhaya V., Sittitrai P., Pattarasakulchai T.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-77957363380&partnerID=40&md5=c19b289f90e489b3d48163a7262dbf22; http://www.ncbi.nlm.nih.gov/pubmed/21611042; http://cmuir.cmu.ac.th/handle/6653943832/2566

Objective: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) for locally advanced head and neck cancer has been studied in many clinical trials. This study was conducted to determine the response rate of IC with paclitaxel, ifosfamide, and cisplatin followed by CCRT with cisplatin...